TELEFLEX INCORPORATED

TFX ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $2.45B $2.15B $1.87B $1.81B $1.84B $1.70B $1.55B $1.49B
Cost of Revenue $1.15B $974.5M $871.8M $865.3M $897.4M $857.3M $802.8M $783.8M
Gross Profit $1.30B $1.17B $996.2M $944.4M $942.4M $838.9M $748.2M $708.8M
Gross Margin 53.2% 54.6% 53.3% 52.2% 51.2% 49.5% 48.2% 47.5%
Operating Expenses
Research & Development $106.2M $84.8M $58.6M $52.1M $61.0M $65.0M $56.3M $48.7M
SG&A Expense $797.1M $700.0M $563.3M $569.0M $578.7M $502.2M $454.5M $423.9M
Operating Income $321.7M $372.3M $319.5M $315.9M $284.9M $233.3M $-97.4M $229.6M
Operating Margin 13.1% 17.3% 17.1% 17.5% 15.5% 13.8% -6.3% 15.4%
Interest Expense $103.0M $82.5M $54.9M $61.3M $65.5M $56.9M $69.6M $70.3M
Pretax Income $219.6M $284.9M $245.7M $244.6M $220.1M $175.7M $-165.4M $145.1M
Income Tax Expense $23.2M $129.6M $8.1M $7.8M $28.7M $23.5M $16.4M $25.8M
Net Income $200.8M $152.5M $237.4M $244.9M $187.7M $150.9M $-190.1M $323.3M
Net Margin 8.2% 7.1% 12.7% 13.5% 10.2% 8.9% -12.3% 21.7%
EPS (Basic) $4.39 $3.39 $5.48 $5.89 $4.54 $3.67 $-4.65 $7.98
EPS (Diluted) $4.29 $3.27 $4.98 $5.10 $4.04 $3.45 $-4.65 $7.92
Shares Outstanding (Basic) 45.7M 45.0M 43.3M 41.6M 41.4M 41.1M 40.9M 40.5M
Shares Outstanding (Diluted) 46.8M 46.7M 47.6M 48.1M 46.5M 43.7M 40.9M 40.8M
Dividends Per Share $1.36 $1.36 $1.36 $1.36 $1.36 $1.36 $1.36 $1.36
← Newer Page 2 of 3 Older →